EUVIMEDEUVIMED entdecken
Crossref

Potential Anti‐inflammatory Compounds in Shaoyao Decoction to Treat Ulcerative Colitis Explored by Bioaffinity Ultrafiltration Liquid Chromatography‐Mass Spectrometry With Multiple Drug Targets

Shujun Wang, Xiaowen Hua, Dan Liu, Satyajit Dey Sarker, Lutfun Nahar, Yingying Zhang, Mingquan Guo

Journal of Separation Science · 2026-11 · 49 (11)

DOI: 10.1002/jssc.70576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Separation Science, online erschienen am 05.11.2026. Verfasst von Shujun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Cixi Hospital, Wenzhou Medical University, Cixi, P. R. China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Drugs, Chinese Herbal, Anti-Inflammatory Agents. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Ningbo Yongjiang Talent Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shaoyao Decoction (SYD) demonstrates therapeutic efficacy in ulcerative colitis (UC), though its active components are still unclear. The present investigation was conducted to comprehensively identify those major constituents of SYD responsible for therapeutic action, focusing on their interaction with important inflammation‐related mediators, NOD‐, LRR‐, and pyrin domain‐containing protein 3 (NLRP3), interleukin‐6 (IL‐6), and cyclooxygenase‐2 (COX‐2). In view of this, ultra‑high‑performance liquid chromatography–quadrupole time‑of‑flight tandem mass spectrometry (UHPLC‐Q‐TOF‐MS/MS) coupled with a multi‐target affinity ultrafiltration strategy was established for the screening of bioactive compounds. Analysis performed by UHPLC‐Q‐TOF‐MS/MS indicated the presence of 43 compounds within SYD. Positive‐ion‐mode analysis resulted in the identification of 24 constituents; most of them are flavonoids, including baicalin, jatrorrhizine, and wogonin 7‐O‐glucuronide. Under negative ion conditions, 23 compounds were detected; these were mainly organic acids and glycosides, including 4,5‐dicaffeoylquinic acid, liquiritin, and gallic acid. The bioaffinity ultrafiltration selection profiles indicated that the compounds jatrorrhizine, gallic acid, glycyrrhizic acid, 4,5‐dicaffeoylquinic acid, wogonin 7‐O‐glucuronide, and galloyl paeoniflorin exhibited excellent binding capability with the three inflammatory target enzymes. Notably, jatrorrhizine exhibited binding activity with all three target enzymes in positive ion mode. Gallic acid achieved a binding affinity of 54.68% for IL‐6 in negative ion mode, and compounds glycyrrhizic acid, 4,5‐dicaffeoylquinic acid, wogonin 7‐O‐glucuronide, and galloyl paeoniflorin, among others, all exhibited strong binding affinities for both NLRP3 and COX‐2. Molecular docking simulations reinforced these binding findings, further substantiating the potential synergistic mechanisms by which SYD components act upon the inflammatory targets. This study characterizes the chemical profiling of SYD and reveals that jatrorrhizine, gallic acid, glycyrrhizic acid, 4,5‐dicaffeoylquinic acid, wogonin 7‐O‐glucuronide, and galloyl paeoniflorin may serve as the primary bioactive components in SYD for treating UC through inhibition of COX‐2, NLRP3, and IL‐6, thereby offering theoretical support for its clinical use and future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeDrugs, Chinese HerbalAnti-Inflammatory AgentsUltrafiltrationHumansLiquid Chromatography-Mass SpectrometryChromatography, High Pressure LiquidMolecular Docking SimulationTandem Mass SpectrometryInterleukin-6

Stichwörter der Autor:innen

Shaoyao decoctionbioaffinity ultrafiltrationmulti‐target screeningulcerative colitis

Substanzen

Drugs, Chinese HerbalAnti-Inflammatory AgentsInterleukin-6

Autor:innen und Institutionen

  • Affiliated Cixi Hospital, Wenzhou Medical University, Cixi, P. R. China.
  • Laboratory of Advanced Theranostic Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, P. R. China.
  • Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Cixi Institute of Biomedical Engineering…
  • Jiangxi Province Key Laboratory of Drug Target Discovery and Validation, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
  • Laboratory of Growth Regulators, Palacký University and Institute of Experimental Botany, The Czech Academy of Sciences, Olomouc, Czech Republic.

Förderung

  • Ningbo Yongjiang Talent Programme

Zitieren

APA

Wang, S., Hua, X., Liu, D., Sarker, S. D., Nahar, L., Zhang, Y., & Guo, M. (2026). Potential Anti‐inflammatory Compounds in Shaoyao Decoction to Treat Ulcerative Colitis Explored by Bioaffinity Ultrafiltration Liquid Chromatography‐Mass Spectrometry With Multiple Drug Targets. Journal of Separation Science, 49(11). https://doi.org/10.1002/jssc.70576

Vancouver

Wang S, Hua X, Liu D, Sarker SD, Nahar L, Zhang Y, et al. Potential Anti‐inflammatory Compounds in Shaoyao Decoction to Treat Ulcerative Colitis Explored by Bioaffinity Ultrafiltration Liquid Chromatography‐Mass Spectrometry With Multiple Drug Targets. Journal of Separation Science. 2026;49(11). doi:10.1002/jssc.70576

BibTeX
@article{Wang2026,
  author = {Wang, Shujun and Hua, Xiaowen and Liu, Dan and Sarker, Satyajit Dey and Nahar, Lutfun and Zhang, Yingying and Guo, Mingquan},
  title = {Potential Anti‐inflammatory Compounds in Shaoyao Decoction to Treat Ulcerative Colitis Explored by Bioaffinity Ultrafiltration Liquid Chromatography‐Mass Spectrometry With Multiple Drug Targets},
  journal = {Journal of Separation Science},
  year = {2026},
  volume = {49},
  number = {11},
  doi = {10.1002/jssc.70576}
}
Kostenlos starten →